-
Article
Open AccessEfficacy of MAGE-A4 long peptide as a universal immunoprevention cancer vaccine
The clinical application of peptide vaccines in tumor immunotherapy holds significant promise. Peptide-based tumor vaccines are currently subject to certain limitations in clinical trials, including the challe...
-
Article
Open AccessFGFR2 alteration as a potential therapeutic target in poorly cohesive gastric carcinoma
Poorly cohesive (PC) is a unique histologic subtype of gastric cancer (GC), with an increasing incidence in recent years. However, the molecular characteristics and therapeutic targets of PC GC are not yet wel...
-
Chapter
Personalized Intraperitoneal Strategies in Gastric Cancer
Gastric cancer is the fourth most common cancer and the second leading cause of cancer deaths worldwide [1]. Except countries such as Korea and Japan that have routine national screening programs, most patient...
-
Chapter
Customized Chemotherapy in Advanced Gastric Cancer
Currently, the therapeutic management of gastric cancer is based largely on clinical data and histological features. Numerous promising markers have been studied in an effort to identify those that will enable...
-
Article
MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancer
Currently, only trastuzumab, ramucirumab, and apatinib effectively treat gastric cancer. Thus, additional novel targets are required for this disease.
